Kronos Bio Inc (KRON)
1.02
-0.01
(-0.97%)
USD |
NASDAQ |
May 03, 16:00
1.01
-0.01
(-0.98%)
After-Hours: 20:00
Kronos Bio Market Cap: 61.30M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 61.30M |
| May 02, 2024 | 61.90M |
| May 01, 2024 | 61.90M |
| April 30, 2024 | 61.90M |
| April 29, 2024 | 60.10M |
| April 26, 2024 | 60.10M |
| April 25, 2024 | 58.89M |
| April 24, 2024 | 57.69M |
| April 23, 2024 | 57.09M |
| April 22, 2024 | 57.69M |
| April 19, 2024 | 60.70M |
| April 18, 2024 | 61.90M |
| April 17, 2024 | 62.50M |
| April 16, 2024 | 65.50M |
| April 15, 2024 | 68.51M |
| April 12, 2024 | 67.91M |
| April 11, 2024 | 67.91M |
| April 10, 2024 | 67.31M |
| April 09, 2024 | 67.91M |
| April 08, 2024 | 72.11M |
| April 05, 2024 | 73.92M |
| April 04, 2024 | 72.11M |
| April 03, 2024 | 75.72M |
| April 02, 2024 | 76.32M |
| April 01, 2024 | 82.93M |
| Date | Value |
|---|---|
| March 28, 2024 | 78.12M |
| March 27, 2024 | 74.52M |
| March 26, 2024 | 71.51M |
| March 25, 2024 | 73.92M |
| March 22, 2024 | 76.32M |
| March 21, 2024 | 72.11M |
| March 20, 2024 | 72.72M |
| March 19, 2024 | 69.71M |
| March 18, 2024 | 69.11M |
| March 15, 2024 | 69.71M |
| March 14, 2024 | 68.51M |
| March 13, 2024 | 68.67M |
| March 12, 2024 | 66.31M |
| March 11, 2024 | 73.09M |
| March 08, 2024 | 76.04M |
| March 07, 2024 | 76.04M |
| March 06, 2024 | 70.74M |
| March 05, 2024 | 60.12M |
| March 04, 2024 | 62.48M |
| March 01, 2024 | 60.12M |
| February 29, 2024 | 61.30M |
| February 28, 2024 | 72.50M |
| February 27, 2024 | 74.86M |
| February 26, 2024 | 67.20M |
| February 23, 2024 | 63.07M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
43.74M
Minimum
Nov 14 2023
2.142B
Maximum
Nov 24 2020
576.98M
Average
234.30M
Median
Jun 07 2022
Market Cap Benchmarks
| CEL-SCI Corp | 87.99M |
| AIM ImmunoTech Inc | 20.20M |
| IGC Pharma Inc | 32.58M |
| NovaBay Pharmaceuticals Inc | 2.856M |
| Protalix BioTherapeutics Inc | 83.28M |
Market Cap Related Metrics
| PS Ratio | 9.366 |
| Price to Book Value | 0.3853 |
| Price | 1.02 |
| Earnings Yield | -191.2% |